Michael Korman in Darby, Pennsylvania

Home Pennsylvania Darby

Michael Korman has Pulmonary Disease as his primary medical specialty. Their primary office is: 1503 Lansdowne Ave in Darby, Pennsylvania.

They're a part of the: Pulmonary Medical Consultants Inc medical group which has around 3 members. You can call their office at 610-534-6140 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Jefferson Medical College Of Thomas Jefferson University and graduated in 1981 (around 43 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Michael J Korman Office Phone and Directions

Michael Korman
Pulmonary Medical Consultants Inc
1503 Lansdowne Ave
Darby, Pennsylvania 19023
610-534-6140

Patient Ratings
Please rate your experience with Michael Korman below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 610-534-6140

Enter a starting address:

Healthcare Info for Michael Korman

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), INTERNAL MEDICINE

Medical School: Jefferson Medical College Of Thomas Jefferson University
Graduation Year: 1981
The Primary Medical Specialty for Michael Korman is listed as: Pulmonary Disease
Approximate Years of Experience: 43
PAC (PECOS ID)#: 1052398286
NPI #: 1316950132
NPI Created On: 08/14/2006
NPI Last Updated Listed as: 03/10/2021
Primary Taxonomy Code: 207R00000X
License Number:
MD028037E
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Highmark Health Insurance Company
AmeriHealth HMO, Inc.
Humana
Highmark Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Hindi, English.

Services and Procedures include:

Ventilation assistance and management, hospital inpatient or observation
Ventilation assistance and management, nursing facility per day
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Diagnostic testing in a pulmonary function lab
Test for exercise-induced lung stress
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Initial nursing facility visit, typically 35 minutes per day
Subsequent nursing facility visit, typically 15 minutes per day
Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $2

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801605507

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801910497

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801974123

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802080999

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802298889

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802832641

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $6

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802871455

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802959749

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802967757

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802969991

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Pulmonary Disease Professionals in Darby

1.
Jaber Monla-hassan MD

1500 Lansdowne Ave
Darby, PA
Critical Care Physicians Of Pennsylvania Pc

2.
Francis Brahmakulam

1503 Lansdowne Ave
Darby, PA
Pulmonary Medical Consultants Inc

3.
Ajay Pillai MD

1503 Lansdowne Ave
Darby, PA
Pulmonary Medical Consultants Inc

Providers in Pulmonary Medical Consultants Inc

1.Francis Brahmakulam

1503 Lansdowne Ave
Darby Pa 19023-1307
Pulmonary Medical Consultants Inc
Pulmonary Disease

2.Michael Korman

1503 Lansdowne Ave
Darby Pa 19023-1307
Pulmonary Medical Consultants Inc
Pulmonary Disease

3.Ajay Pillai Md

1503 Lansdowne Ave
Darby Pa 19023-1307
Pulmonary Medical Consultants Inc
Pulmonary Disease

View all 3 members of Pulmonary Medical Consultants Inc medical group